Search
News articles
News and media
"It's only now that I have seen the impact macular disease has on people"
News articles
Media and press office
News and media
We’re here to answer all your questions about macular disease. We provide expert comment on developments in treatments and research and what this means for patients living with the UK’s biggest cause of sight loss.
Podcast mini series shines light on extra financial support
Latest news, posted 2 January 2024
Living with sight loss may entitle you to extra financial support to help with day-to-day costs, but do you know what you can claim?
Online support for early onset macular degeneration
Latest news, posted 8 January 2024
A new support group for people with early onset macular degeneration – a condition many often confuse with early age-related macular degeneration (AMD) – will launch next month.
‘I feel so incredibly lucky to have had the opportunity to work for such a wonderful organisation’
Latest news, posted 12 January 2024
After nearly a decade of dedicated service as chief executive of leading sight loss charity the Macular Society, Cathy Yelf has announced her decision to retire in 2024.
Michael Owen prays for a cure for son's Stargardt
Latest news, posted 23 January 2024
Michael Owen has brought Stargardt into the spotlight again as he talks about his son's diagnosis.
'Do the things that make you feel worthwhile'
Latest news, posted 24 January 2024
The loneliness and isolation associated with sight loss can be detrimental to our mental health, but volunteer Carol is on a mission to emotionally lift and encourage others.
Dedicated group for those supporting people with macular disease launches
Latest news, posted 25 January 2024
A new dedicated support group for caregivers and those supporting people living with macular disease will launch this spring, recognising their often-overlooked needs.
Another new drug offers hope for Stargardt patients
Latest news, posted 29 January 2024
Another drug to potentially treat Stargardt has shown positive results in slowing down the progression of the disease in a recent trial.